Is intraperitoneal chemotherapy beneficial in pancreatic cancer?

The role of intraperitoneal chemotherapy has been widely investigated in locally advanced malignancies which serosal involvement as well as in cases in which disseminated peritoneal nodules are present. However, its benefits have been widely contested by the higher rates of perioperative complicatio...

Full description

Bibliographic Details
Main Authors: Irina Balescu, Nicolae Bacalbasa, Claudia Stoica, Lucian Pop, Valentin Varlas, Cristina Martac, Andrei Voichitoiu, Tarig Massawi
Format: Article
Language:English
Published: Amaltea Medical Publishing House 2022-06-01
Series:Romanian Journal of Medical Practice
Subjects:
Online Access:https://rjmp.com.ro/articles/2022.2/RJMP_2022_2_Art-09.pdf
_version_ 1827952038116327424
author Irina Balescu
Nicolae Bacalbasa
Claudia Stoica
Lucian Pop
Valentin Varlas
Cristina Martac
Andrei Voichitoiu
Tarig Massawi
author_facet Irina Balescu
Nicolae Bacalbasa
Claudia Stoica
Lucian Pop
Valentin Varlas
Cristina Martac
Andrei Voichitoiu
Tarig Massawi
author_sort Irina Balescu
collection DOAJ
description The role of intraperitoneal chemotherapy has been widely investigated in locally advanced malignancies which serosal involvement as well as in cases in which disseminated peritoneal nodules are present. However, its benefits have been widely contested by the higher rates of perioperative complications and therefore, the guidelines did not include it as part of standard therapy. Meanwhile, the better control of the intraperitoneal spread which has been demonstrated in certain cases enabled surgeons to propose performing intraperitoneal chemotherapy in particularly aggressive malignancies such as pancreatic cancer. The aim of the current paper is to discuss about the efficacy and the preliminary results of intraperitoneal chemotherapy in pancreatic cancer.
first_indexed 2024-04-09T13:51:29Z
format Article
id doaj.art-4ad5b92402734eacb6ed8710616ee705
institution Directory Open Access Journal
issn 1842-8258
2069-6108
language English
last_indexed 2024-04-09T13:51:29Z
publishDate 2022-06-01
publisher Amaltea Medical Publishing House
record_format Article
series Romanian Journal of Medical Practice
spelling doaj.art-4ad5b92402734eacb6ed8710616ee7052023-05-08T15:18:28ZengAmaltea Medical Publishing HouseRomanian Journal of Medical Practice1842-82582069-61082022-06-0117210210410.37897/RJMP.2022.2.9Is intraperitoneal chemotherapy beneficial in pancreatic cancer? Irina Balescu0Nicolae Bacalbasa1Claudia Stoica2Lucian Pop3Valentin Varlas4Cristina Martac5Andrei Voichitoiu6Tarig Massawi7Department of Visceral Surgery, Ponderas Academic Hospital, Bucharest, RomaniaDepartment of Obstetrics and Gynecology, “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania; Department of Visceral Surgery, Center of Excellence in Translational Medicine, Fundeni Clinical Institute, Bucharest, RomaniaDepartment of Anatomy, “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania; Department of Surgery, Ilfov County Emergency Hospital, Bucharest, RomaniaDepartment of Obstetrics and Gynecology, ”Alessandrescu-Rusescu”National Institute of Mother and Child Care, Bucharest, RomaniaDepartment of Obstetrics and Gynecology, “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania; Department of Obstetrics and Gynecology, Filantropia Clinical Hospital, Bucharest, RomaniaDepartment of Anesthesiology, Fundeni Clinical Institute, Bucharest, RomaniaDepartment of Obstetrics and Gynecology, “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania; Department of Obstetrics and Gynecology, ”Alessandrescu-Rusescu”National Institute of Mother and Child Care, Bucharest, RomaniaDepartment of Obstetrics and Gynecology, Ilfov County Emergency Hospital, Bucharest, RomaniaThe role of intraperitoneal chemotherapy has been widely investigated in locally advanced malignancies which serosal involvement as well as in cases in which disseminated peritoneal nodules are present. However, its benefits have been widely contested by the higher rates of perioperative complications and therefore, the guidelines did not include it as part of standard therapy. Meanwhile, the better control of the intraperitoneal spread which has been demonstrated in certain cases enabled surgeons to propose performing intraperitoneal chemotherapy in particularly aggressive malignancies such as pancreatic cancer. The aim of the current paper is to discuss about the efficacy and the preliminary results of intraperitoneal chemotherapy in pancreatic cancer.https://rjmp.com.ro/articles/2022.2/RJMP_2022_2_Art-09.pdfpancreatic cancerintraperitoneal chemotherapylocal controlsurvival
spellingShingle Irina Balescu
Nicolae Bacalbasa
Claudia Stoica
Lucian Pop
Valentin Varlas
Cristina Martac
Andrei Voichitoiu
Tarig Massawi
Is intraperitoneal chemotherapy beneficial in pancreatic cancer?
Romanian Journal of Medical Practice
pancreatic cancer
intraperitoneal chemotherapy
local control
survival
title Is intraperitoneal chemotherapy beneficial in pancreatic cancer?
title_full Is intraperitoneal chemotherapy beneficial in pancreatic cancer?
title_fullStr Is intraperitoneal chemotherapy beneficial in pancreatic cancer?
title_full_unstemmed Is intraperitoneal chemotherapy beneficial in pancreatic cancer?
title_short Is intraperitoneal chemotherapy beneficial in pancreatic cancer?
title_sort is intraperitoneal chemotherapy beneficial in pancreatic cancer
topic pancreatic cancer
intraperitoneal chemotherapy
local control
survival
url https://rjmp.com.ro/articles/2022.2/RJMP_2022_2_Art-09.pdf
work_keys_str_mv AT irinabalescu isintraperitonealchemotherapybeneficialinpancreaticcancer
AT nicolaebacalbasa isintraperitonealchemotherapybeneficialinpancreaticcancer
AT claudiastoica isintraperitonealchemotherapybeneficialinpancreaticcancer
AT lucianpop isintraperitonealchemotherapybeneficialinpancreaticcancer
AT valentinvarlas isintraperitonealchemotherapybeneficialinpancreaticcancer
AT cristinamartac isintraperitonealchemotherapybeneficialinpancreaticcancer
AT andreivoichitoiu isintraperitonealchemotherapybeneficialinpancreaticcancer
AT tarigmassawi isintraperitonealchemotherapybeneficialinpancreaticcancer